跳至主要内容
临床试验/NCT05758909
NCT05758909进行中(未招募)不适用

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation

Fundación EPIC13 个研究点 分布在 1 个国家目标入组 585 人开始时间: 2023年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
585
试验地点
13
主要终点
Assessment of early safety

研究概览

简要总结

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

详细描述

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who meet all of the following conditions will be included:
  • Patients ≥ 18 years undergoing transfemoral TAVI implantation scheduled, performed on an outpatient basis.
  • Patients with percutaneous implant.
  • Patients undergoing the procedure under superficial sedation or Local anesthesia.
  • Patients with baseline narrow QRS that does not change after implantation, or definitive pacemaker carrier.
  • Patients who have signed the informed consent.

排除标准

  • Patients who do not meet any of the following conditions:
  • Patients with a wide QRS (greater than or equal to 120 msec) at baseline, with the except for patients with permanent pacemakers.
  • Hospitalized patients undergoing urgent TAVI implantation.
  • Patients with access other than percutaneous transfemoral.

结局指标

主要结局

Assessment of early safety

时间窗: 30 days

Proportion of patients with early safety defined as: * Cardiovascular death. * Stroke. * Myocardial Infarction. * Hospitalization for any reason . * Major vascular complications. * Need for pacemakers.

次要结局

  • Assessment of Hospitalization for any reason(12 months)
  • Assessment of Stroke(12 months)
  • Assessment of Myocardial Infarction(12 months)
  • Assessments of need for pacemakers(12 months)
  • Assessment of Cardiovascular death(12 months)
  • Assessments of Major Vascular Complications(12 months)
  • Assessment of hospitalization time(at discharge)
  • Assessment of hospitalization due cardiac reasons(30 days)

研究者

发起方
Fundación EPIC
申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验